Anne-Mette Hejl

Anne-Mette Hejl serves as a Clinical Associate Professor in the Department of Clinical Medicine at the University of Copenhagen's Faculty of Health and Medical Sciences. Her academic appointment is specifically within the Neurology division, where she conducts research at the intersection of neurology, immunology, and advanced imaging techniques. Her institutional affiliation includes Region Hovedstaden (Capital Region of Denmark), as indicated by her regionh.dk email address.

Dr. Hejl's research focuses on neurodegenerative disorders, particularly Parkinson's disease and related synucleinopathies. Her work spans multiple domains including neuroimaging techniques (particularly 7 Tesla MRI), autoantibody profiling, and the investigation of pathological mechanisms in neurodegenerative conditions. She has made significant contributions to understanding the structural changes in Parkinson's disease, diagnostic approaches for atypical parkinsonism, and the role of autoimmunity in neurodegenerative processes.

Her publication record shows a consistent trend toward interdisciplinary research that bridges clinical neurology with biochemical and immunological approaches. Recent work has explored advanced imaging techniques for Parkinson's disease diagnosis, standardized detection methods for synucleinopathies, and the complex relationships between autoantibodies and neurodegenerative conditions. Her research demonstrates a strong emphasis on developing more accurate diagnostic tools and understanding disease mechanisms at molecular and structural levels.

Dr. Hejl maintains active collaborations with numerous researchers across Denmark and internationally, as evidenced by her extensive co-authorship network. Her work has been disseminated through high-impact journals in neurology, neuroscience, and medical imaging fields. While specific grant information isn't detailed in the available materials, her research output suggests participation in multiple collaborative projects investigating neurodegenerative disorders.

Her laboratory work appears to focus on neuroimaging analysis, biomarker discovery, and immunological aspects of neurodegenerative diseases. The collaborative nature of her publications indicates she works within multidisciplinary teams that likely include neurologists, imaging specialists, immunologists, and biochemists working together to advance understanding of Parkinson's disease and related conditions.